These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

118 related items for PubMed ID: 18632816

  • 1. Whole-body biodistribution and radiation dosimetry of the new cardiac tracer 99mTc-N-DBODC.
    Cittanti C, Uccelli L, Pasquali M, Boschi A, Flammia C, Bagatin E, Casali M, Stabin MG, Feggi L, Giganti M, Duatti A.
    J Nucl Med; 2008 Aug; 49(8):1299-304. PubMed ID: 18632816
    [Abstract] [Full Text] [Related]

  • 2. 99mTc-N-DBODC5, a new myocardial perfusion imaging agent with rapid liver clearance: comparison with 99mTc-sestamibi and 99mTc-tetrofosmin in rats.
    Hatada K, Riou LM, Ruiz M, Yamamichi Y, Duatti A, Lima RL, Goode AR, Watson DD, Beller GA, Glover DK.
    J Nucl Med; 2004 Dec; 45(12):2095-101. PubMed ID: 15585487
    [Abstract] [Full Text] [Related]

  • 3. Pharmacokinetics and biodistribution of 99mTc N-MPO in healthy human volunteers.
    Gao S, Zhao G, Wen Q, Bai L, Chen B, Ji T, Ji B, Ma Q.
    Clin Nucl Med; 2014 Jan; 39(1):e14-9. PubMed ID: 23917788
    [Abstract] [Full Text] [Related]

  • 4. Technetium-99m-1,2-bis[bis(2-ethoxyethyl) phosphino]ethane: human biodistribution, dosimetry and safety of a new myocardial perfusion imaging agent.
    Higley B, Smith FW, Smith T, Gemmell HG, Das Gupta P, Gvozdanovic DV, Graham D, Hinge D, Davidson J, Lahiri A.
    J Nucl Med; 1993 Jan; 34(1):30-8. PubMed ID: 8418268
    [Abstract] [Full Text] [Related]

  • 5. [Myocardial perfusion imaging with [(99m)Tc (N) (PNP5) (DBODC)](+) in canine model of acute myocardial ischemia].
    Zhang WC, Fang W, Wang XB, Li B, Tang ZG, Guo F, Guo L, Geng QH, He ZX.
    Zhonghua Xin Xue Guan Bing Za Zhi; 2007 Oct; 35(10):949-55. PubMed ID: 18206048
    [Abstract] [Full Text] [Related]

  • 6. Biodistribution and dosimetry of 99mTc-BTAP-annexin-V in humans.
    Kemerink GJ, Boersma HH, Thimister PW, Hofstra L, Liem IH, Pakbiers MT, Janssen D, Reutelingsperger CP, Heidendal GA.
    Eur J Nucl Med; 2001 Sep; 28(9):1373-8. PubMed ID: 11585297
    [Abstract] [Full Text] [Related]

  • 7. Biodistribution, dosimetry, and safety of myocardial perfusion imaging agent 99mTcN-NOET in healthy volunteers.
    Vanzetto G, Fagret D, Pasqualini R, Mathieu JP, Chossat F, Machecourt J.
    J Nucl Med; 2000 Jan; 41(1):141-8. PubMed ID: 10647617
    [Abstract] [Full Text] [Related]

  • 8. Experimental study of [99mTc(PNP5) (DBODC)]+ as a new myocardial perfusion imaging agent.
    Zhang WC, Fang W, Li B, Wang XB, He ZX.
    Cardiology; 2009 Jan; 112(2):89-97. PubMed ID: 18583906
    [Abstract] [Full Text] [Related]

  • 9. Myocardial technetium-99m-tetrofosmin and technetium-99m-sestamibi kinetics in normal subjects and patients with coronary artery disease.
    Münch G, Neverve J, Matsunari I, Schröter G, Schwaiger M.
    J Nucl Med; 1997 Mar; 38(3):428-32. PubMed ID: 9074532
    [Abstract] [Full Text] [Related]

  • 10. A class of asymmetrical nitrido 99mTc heterocomplexes as heart imaging agents with improved biological properties.
    Boschi A, Bolzati C, Uccelli L, Duatti A, Benini E, Refosco F, Tisato F, Piffanelli A.
    Nucl Med Commun; 2002 Jul; 23(7):689-93. PubMed ID: 12089492
    [Abstract] [Full Text] [Related]

  • 11. Biokinetics and dosimetry analysis in healthy volunteers for a two-injection (rest-stress) protocol of the myocardial perfusion imaging agent technetium 99m-labeled Q3.
    Rohe RC, Thomas SR, Stabin MG, Deutsch EA, Gerson MC, Cummings DD, Maxon HR.
    J Nucl Cardiol; 1995 Jul; 2(5):395-404. PubMed ID: 9420819
    [Abstract] [Full Text] [Related]

  • 12. [Phase I clinical trial of a new myocardial imaging agent, 99mTc-PPN1011].
    Kubo A, Nakamura K, Hashimoto J, Sammiya T, Iwanaga S, Hashimoto S, Sasaki Y.
    Kaku Igaku; 1992 Oct; 29(10):1165-76. PubMed ID: 1464955
    [Abstract] [Full Text] [Related]

  • 13. Human biodistribution, dosimetry and clinical use of technetium(III)-99m-Q12.
    Rossetti C, Vanoli G, Paganelli G, Kwiatkowski M, Zito F, Colombo F, Bonino C, Carpinelli A, Casati R, Deutsch K.
    J Nucl Med; 1994 Oct; 35(10):1571-80. PubMed ID: 7931652
    [Abstract] [Full Text] [Related]

  • 14. Effect of time on liver clearance of technetium-99m-tetrofosmin in patients with acute chest pain: when should imaging begin?
    Mann A, Ahlberg AW, White MP, Cross DM, Piriz J, Morris RS, Heller GV.
    J Nucl Med Technol; 1998 Sep; 26(3):186-90. PubMed ID: 9755438
    [Abstract] [Full Text] [Related]

  • 15. Safety, biodistribution, and dosimetry of 99mTc-HYNIC-annexin V, a novel human recombinant annexin V for human application.
    Kemerink GJ, Liu X, Kieffer D, Ceyssens S, Mortelmans L, Verbruggen AM, Steinmetz ND, Vanderheyden JL, Green AM, Verbeke K.
    J Nucl Med; 2003 Jun; 44(6):947-52. PubMed ID: 12791824
    [Abstract] [Full Text] [Related]

  • 16. Subcellular distribution and metabolism studies of the potential myocardial imaging agent [99mTc(N)(DBODC)(PNP5)]+.
    Bolzati C, Cavazza-Ceccato M, Agostini S, Tokunaga S, Casara D, Bandoli G.
    J Nucl Med; 2008 Aug; 49(8):1336-44. PubMed ID: 18632814
    [Abstract] [Full Text] [Related]

  • 17. Comparison of 99mTc-tetrofosmin uptakes on planar images with those in excised rats organs.
    Onoguchi M, Takayama T, Tonami N, Kyogoku S, Naoi Y, Irimoto M, Maehara T.
    Ann Nucl Med; 2001 Feb; 15(1):33-40. PubMed ID: 11355779
    [Abstract] [Full Text] [Related]

  • 18. Influence of the different biokinetics of sestamibi and tetrofosmin on the interpretation of myocardial perfusion imaging in daily practice.
    Hambÿe AS, Delsarte P, Vervaet AM.
    Nucl Med Commun; 2007 May; 28(5):383-90. PubMed ID: 17414888
    [Abstract] [Full Text] [Related]

  • 19. Evaluation of novel cationic (99m)Tc-nitrido complexes as radiopharmaceuticals for heart imaging: improving liver clearance with crown ether groups.
    Liu S, He Z, Hsieh WY, Kim YS.
    Nucl Med Biol; 2006 Apr; 33(3):419-32. PubMed ID: 16631092
    [Abstract] [Full Text] [Related]

  • 20. Technetium-99m-tetrofosmin in dipyridamole-stress myocardial SPECT imaging: intraindividual comparison with technetium-99m-sestamibi.
    Flamen P, Bossuyt A, Franken PR.
    J Nucl Med; 1995 Nov; 36(11):2009-15. PubMed ID: 7472590
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.